Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

被引：0
|
作者：
Alice Indini
Lorenza Di Guardo
Carolina Cimminiello
Michele Prisciandaro
Giovanni Randon
Filippo De Braud
Michele Del Vecchio
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology
[2] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Department of Medical Oncology and Hematology
[3] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Università degli studi di Milano
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Melanoma; Immunotherapy; Anti-PD1; IrAEs; Vitiligo; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：511 / 521
页数：10
相关论文
共 50 条
  • [1] Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
    Indini, Alice
    Di Guardo, Lorenza
    Cimminiello, Carolina
    Prisciandaro, Michele
    Randon, Giovanni
    De Braud, Filippo
    Del Vecchio, Michele
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (02) : 511 - 521
  • [2] Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
    Owen, C. N.
    Bai, X.
    Quah, T.
    Lo, S. N.
    Allayous, C.
    Callaghan, S.
    Martinez-Vila, C.
    Wallace, R.
    Bhave, P.
    Reijers, I. L. M.
    Thompson, N.
    Vanella, V.
    Gerard, C. L.
    Aspeslagh, S.
    Labianca, A.
    Khattak, A.
    Mandala, M.
    Xu, W.
    Neyns, B.
    Michielin, O.
    Blank, C. U.
    Welsh, S. J.
    Haydon, A.
    Sandhu, S.
    Mangana, J.
    McQuade, J. L.
    Ascierto, P. A.
    Zimmer, L.
    Johnson, D. B.
    Arance, A.
    Lorigan, P.
    Lebbe, C.
    Carlino, M. S.
    Sullivan, R. J.
    Long, G., V
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2021, 32 (07) : 917 - 925
  • [3] Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
    Suo, Aleksi
    Chan, Yin
    Beaulieu, Carissa
    Kong, Shiying
    Cheung, Winson Y.
    Monzon, Jose G.
    Smylie, Michael
    Walker, John
    Morris, Don
    Cheng, Tina
    ONCOLOGIST, 2020, 25 (05) : 438 - 446
  • [4] Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
    Cortellini, Alessio
    Chiari, Rita
    Ricciuti, Biagio
    Metro, Giulio
    Perrone, Fabiana
    Tiseo, Marcello
    Bersanelli, Melissa
    Bordi, Paola
    Santini, Daniele
    Giusti, Raffaele
    Grassadonia, Antonino
    Di Marino, Pietro
    Tinari, Nicola
    De Tursi, Michele
    Zoratto, Federica
    Veltri, Enzo
    Malorgio, Francesco
    Garufi, Carlo
    Russano, Marco
    Anesi, Cecilia
    Zeppola, Tea
    Filetti, Marco
    Marchetti, Paolo
    Berardi, Rossana
    Rinaldi, Silvia
    Tudini, Marianna
    Silva, Rosa Rita
    Pireddu, Annagrazia
    Atzori, Francesco
    Iacono, Daniela
    Migliorino, Maria Rita
    Porzio, Gampiero
    Cannita, Katia
    Ficorella, Corrado
    Buti, Sebastiano
    CLINICAL LUNG CANCER, 2019, 20 (04) : 237 - +
  • [5] Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
    Pollack, M. H.
    Betof, A.
    Dearden, H.
    Rapazzo, K.
    Valentine, I.
    Brohl, A. S.
    Ancell, K. K.
    Long, G. V.
    Menzies, A. M.
    Eroglu, Z.
    Johnson, D. B.
    Shoushtari, A. N.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 250 - 255
  • [6] Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy
    Shafqat, Hammad
    Gourdin, Theodore
    Sion, Amy
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 156 - 163
  • [7] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
    Wu, Chiao-En
    Yang, Chan-Keng
    Peng, Meng-Ting
    Huang, Pei-Wei
    Chang, Ching-Fu
    Yeh, Kun-Yun
    Chen, Chun-Bing
    Wang, Chih-Liang
    Hsu, Chao-Wei
    Chen, I-Wen
    Lin, Cheng-Tao
    Ueng, Shir-Hwa
    Lin, Gigin
    Lin, Yu-Fen
    Cheng, Chi-Yuan
    Chang, John Wen-Cheng
    BMC CANCER, 2020, 20 (01)
  • [8] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
    Chiao-En Wu
    Chan-Keng Yang
    Meng-Ting Peng
    Pei-Wei Huang
    Ching-Fu Chang
    Kun-Yun Yeh
    Chun-Bing Chen
    Chih-Liang Wang
    Chao-Wei Hsu
    I-Wen Chen
    Cheng-Tao Lin
    Shir-Hwa Ueng
    Gigin Lin
    Yu-Fen Lin
    Chi-Yuan Cheng
    John Wen-Cheng Chang
    BMC Cancer, 20
  • [9] Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy
    Sidhu, Parveen
    Menzies, Alexander M.
    Long, Georgina
    Carlino, Matteo
    Lorens, Shirleen
    Kapoor, Rony
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 61 (06) : 759 - 766
  • [10] Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma
    Dawidowska, Anna
    Jagodzinska-Mucha, Paulina
    Kosela-Paterczyk, Hanna
    Jaczewska, Sylwia
    Sobczuk, Pawel
    Chelstowska, Monika
    Kowalska, Maria
    Badziak-Sterczewska, Honorata
    Poleszczuk, Jan
    Rutkowski, Piotr
    Lugowska, Iwona
    CANCERS, 2022, 14 (05)
12345